Promotion of Research & Innovation in Pharma-MedTech sector (PRIP) scheme

August 31, 2023

The Union Cabinet has approved the Promotion of Research & Innovation in Pharma-MedTech sector (PRIP) scheme with an outlay of ₹5,000 crore for five years, from 2023-24 to 2027-28.
The objective of the PRIP scheme is to transform the Indian Pharma MedTech sector from cost-based competitiveness to innovation-based growth by strengthening the research infrastructure in the country.
Ministry- Minister for Chemicals and Fertilizers
The scheme will be in two parts:
- preparing capacity in PSUs;
- provide support to private sector for research.
In the first components- National Institutes of Pharmaceutical, Education & Research (NIPERs) in Mohali, Ahmedabad, Hyderabad, Rae Bareli, Guwahati, Hajipur and Kolkata will focus on research across categories like anti-viral and anti-bacterial drug discovery and development, medical device making, R&D in bulk drugs, novel drug delivery system, phytopharmaceuticals and bilogical therapeutics.
- ₹700 crore fund is allocated to this part.
The second component, targeting the private sector includes development of new chemical entity (or molecular entity), complex generics and biosimilars, precision medicines (used in stem cell technology and gene therapy), medical devices (leveraging Artificial Intelligence and Machine Learning), orphan drugs (including rare diseases) and research on anti-microbial resistance.
- Another ₹4,250 crore will be allocated under this component.